St. Vincent's Hospital
Melbourne 3065
3 studies enrolling now · 16 studies all time
What they study most
Acute Respiratory Failure, Advanced Solid Tumor, Bladder Carcinoma, Brain and Central Nervous System Tumors, Breast Cancer, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chronic Hepatitis C, Chronic Lymphocytic Leukemia, Colorectal Cancer, Crohn's Disease, Diabetes Mellitus, Type 1
Studies at this site
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
- Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study — Recruiting now
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
- A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling
- Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
- IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) — Stopped early
- A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours — Stopped early
- Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) — Running, not enrolling
- Dysport® Adult Lower Limb Spasticity Follow-on Study — Completed
- Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis — Stopped early
- Third International Study on Mechanical Ventilation — Completed
- Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) — Stopped early
- Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon — Completed